Lantheus Holdings Inc. is weighing a sale after getting a takeover offer from Curium that values the radiopharma company at about $7 billion, according to people familiar with the matter.

Full article body is being fetched in the background. Refresh in a moment to see the complete paragraphs. For now this page shows a summary and AI analysis.